ITMN4077

CAS No. 790305-05-4

ITMN4077( —— )

Catalog No. M24786 CAS No. 790305-05-4

ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ITMN4077
  • Note
    Research use only, not for human use.
  • Brief Description
    ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
  • Description
    ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    790305-05-4
  • Formula Weight
    568.68
  • Molecular Formula
    C26H40N4O8S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (175.85 mM)
  • SMILES
    CC(C)(C)OC(N[C@@H](CCCCC/C=C\[C@H](C1)[C@]1(C(NS(C1CC1)(=O)=O)=O)NC([C@H](C1)N2C[C@@H]1O)=O)C2=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pipequaline hydrochl...

    Pipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed.

  • Antiviral agent 34

    Antiviral agent 34 is an orally available, potent antiviral compound that inhibits influenza A and B viruses.

  • BIT225

    BIT225 is a human immunodeficiency virus type 1 Vpu inhibitor with antiviral activity that inhibits HIV-1 replication in bone marrow dendritic cells and inhibits ion channels formed by HIV-1 Vpu.